FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new peptidomimetic macrocycles and methods for using these macrocycles to modulate p53 and/or HDM2, HDMX activity.
EFFECT: producing new compounds.
33 cl, 8 dwg, 4 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| p53 PEPTIDOMIMETIC MACROCYCLES | 2013 |
|
RU2642299C2 |
| PEPTIDOMIMETIC MACROCYCLES AND THEIR APPLICATION | 2012 |
|
RU2639523C2 |
| PEPTIDES HAVING AGONISTIC ACTIVITY ON NEUROPEPTIDE-2 RECEPTOR (Y2R) | 2006 |
|
RU2383553C2 |
| BINDING ANTIBODY POLYPEPTIDE, BINDING ANTIBODY HYBRID POLYPEPTIDE AND ADSORPTION MATERIAL | 2015 |
|
RU2663998C1 |
| FUSED DRUG CONSTRUCTS AND CONJUGATES | 2005 |
|
RU2428431C2 |
| COMPOSITION AND IMMUNIZATION METHOD, METHODS FOR PRODUCING NON-NATURAL, ORDERED AND REPEATED ANTIGEN MASSIVE AND COAT PROTEIN | 2002 |
|
RU2295973C2 |
| COMPOSITION AND METHOD FOR IMMUNIZATION, METHOD FOR PRODUCING OF NON-NATURAL, ORDERED AND REPEATED ANTIGEN MASSIVE | 2002 |
|
RU2294211C2 |
| INHIBITORS OF XA FACTOR | 1995 |
|
RU2152954C1 |
| COMPOSITION AND METHOD FOR IMMUNISATION, METHOD OF PRODUCING UNNATURAL, ORDERED AND REPEATING MASSIVE OF ANTIGENS | 2002 |
|
RU2438701C2 |
| MUCIN HYPERSECRETION INHIBITORS AND METHODS OF APPLICATION THEREOF | 2006 |
|
RU2423379C2 |
